Migraine Treatment: When to See a Doctor and What Helps
The exact cause of migraine is not fully understood, but research has advanced significantly in recent decades. What is known is that migraine is a neurological condition involving changes in brain activity, nerve signalling, and blood flow. It is not simply a bad headache. It is a complex neurological event that can affect the entire body.
Migraine tends to run in families. According to the Brain Foundation Australia, people with a first-degree relative who experiences migraine are significantly more likely to develop the condition themselves. Genetic factors influence how the brain responds to certain triggers and how pain pathways are activated.
At the neurological level, current research suggests that migraine involves the activation of the trigeminovascular system, a network of nerves and blood vessels that plays a central role in head pain. During a migraine, these nerve pathways become overactive, releasing inflammatory chemicals that irritate blood vessels and surrounding tissues. This process is thought to be responsible for the throbbing, often one-sided pain that characterises many migraine attacks.
Several factors are known to trigger migraine episodes in people who are predisposed. Common triggers include:
- Hormonal changes — Fluctuations in oestrogen are one of the most well-documented triggers. Many women report migraines occurring around menstruation, during perimenopause, or in response to hormonal contraception. Healthdirect Australia notes that hormonal migraine is one of the reasons the condition disproportionately affects women.
- Stress and fatigue — Both physical and emotional stress can trigger an attack. Paradoxically, the onset of relaxation after a period of intense stress (sometimes called a "let-down" migraine) is also a recognised pattern.
- Dietary factors — Certain foods and drinks, including alcohol (particularly red wine), aged cheeses, processed meats, and foods containing MSG, have been identified as triggers in some individuals. Skipping meals or not drinking enough water may also contribute.
- Environmental stimuli — Bright or flickering lights, strong smells, loud sounds, and changes in weather or barometric pressure are all reported triggers.
- Sleep disruption — Both too little and too much sleep can increase the likelihood of an attack. Irregular sleep patterns are a particularly common trigger in shift workers and new parents.
- Medication overuse — Taking pain relief too frequently (typically more than 10 to 15 days per month, depending on the type of medication) can lead to a rebound pattern known as medication overuse headache, which worsens migraine frequency over time.
It is worth noting that triggers are highly individual. What provokes a migraine in one person may have no effect on another. Keeping a headache diary, which tracks the timing, severity, duration, and potential triggers of each attack, can be a useful tool for identifying personal patterns. A GP can help interpret this information and use it to guide treatment.
Many people use the word "migraine" loosely to describe any severe headache, but the two conditions are clinically distinct. Understanding the difference matters because the treatment approach for each is not the same.
A tension-type headache, which is the most common form of headache, typically presents as a dull, constant pressure or tightness on both sides of the head. It may feel like a band around the forehead. Tension headaches are usually mild to moderate in intensity, do not worsen with physical activity, and are not accompanied by nausea or sensitivity to light and sound. They respond well to simple analgesics and tend to resolve within a few hours.
A migraine attack is a different experience. According to the International Headache Society criteria referenced by Healthdirect Australia, a migraine episode typically involves:
- Moderate to severe pain, often on one side of the head (though it can be bilateral)
- A pulsating or throbbing quality to the pain
- Nausea and/or vomiting
- Sensitivity to light (photophobia) and sound (phonophobia)
- Worsening with routine physical activity, such as climbing stairs or bending over
- Duration of 4 to 72 hours if untreated
About one in four people with migraine also experience aura, a set of neurological symptoms that typically develop 5 to 60 minutes before the headache phase begins. Aura most commonly involves visual disturbances such as zigzag lines, flashing lights, or blind spots in the visual field. Less commonly, it can include tingling or numbness in the face or hands, difficulty speaking, or a sense of confusion. Aura symptoms are temporary and fully reversible, but they can be alarming for someone experiencing them for the first time.
There are also less common migraine subtypes, including migraine without headache (sometimes called "silent migraine"), vestibular migraine (where the primary symptom is dizziness or vertigo rather than head pain), and chronic migraine (defined as 15 or more headache days per month, with at least eight of those meeting migraine criteria). A GP or specialist can help distinguish between these subtypes and recommend an appropriate treatment path.
The key point is this: if headaches are recurring, one-sided, throbbing, and accompanied by nausea, light sensitivity, or aura, it is worth discussing with a doctor. What many people dismiss as "just a headache" may be migraine, and migraine has its own set of treatment options that go well beyond standard pain relief.
Acute treatment refers to the medication and strategies used to manage a migraine attack once it has started. The goal is to reduce the severity and duration of the episode and restore the ability to function.
The most effective approach is to treat early. Research published in the Journal of Headache and Pain and referenced by NPS MedicineWise indicates that taking medication at the first sign of an attack, before the pain becomes severe, significantly improves outcomes for many patients.
Over-the-counter options
For mild to moderate migraine attacks, simple analgesics may provide relief. These include:
- Paracetamol — Can be effective when taken early. It is generally well tolerated but may be insufficient for moderate to severe attacks.
- Ibuprofen and other NSAIDs (non-steroidal anti-inflammatory drugs) — Ibuprofen, naproxen, and aspirin have all shown effectiveness in clinical trials for acute migraine. NSAIDs work by reducing the inflammatory response associated with migraine. Soluble or fast-dissolving formulations may be absorbed more quickly, which matters during an attack when gastric motility is often slowed.
- Combination products — Some over-the-counter preparations combine paracetamol or aspirin with caffeine. Caffeine can enhance the analgesic effect and improve absorption. However, frequent use of caffeine-containing analgesics carries a risk of medication overuse headache and should be discussed with a GP.
Prescription options
When over-the-counter treatments are not sufficient, a GP may prescribe more targeted medications. These include:
- Triptans — Triptans (such as sumatriptan, zolmitriptan, and rizatriptan) are a class of medication specifically developed for migraine. They work by narrowing blood vessels in the brain and blocking pain pathways in the trigeminal nerve. Triptans are most effective when taken early in an attack. They are not suitable for everyone, particularly those with certain cardiovascular conditions, and require a doctor's assessment before prescribing.
- Anti-nausea medication — Because nausea is a common feature of migraine and can interfere with the ability to take oral medication, a GP may prescribe an anti-emetic such as metoclopramide or prochlorperazine. These may be taken alongside an analgesic or triptan.
It is important to note that all prescription medications for migraine require a consultation with a doctor. A GP will assess the patient's history, the frequency and severity of attacks, other medications being taken, and any contraindications before determining what is appropriate.
Non-medication strategies
While not a replacement for effective medication, some non-pharmacological strategies may help manage an acute attack:
- Resting in a dark, quiet room
- Applying a cold pack to the forehead or the back of the neck
- Staying hydrated
- Practising slow, controlled breathing
These strategies are most useful as complements to medication, not substitutes, particularly for moderate to severe episodes.
For people who experience frequent migraines, particularly those with four or more attacks per month, preventive treatment may be worth discussing with a GP. The aim of preventive therapy is to reduce the frequency, severity, and duration of attacks over time. It does not eliminate migraine entirely in most cases, but it can make a significant difference to quality of life.
The decision to start preventive treatment is a clinical one, made in partnership between the patient and their doctor. Factors that may prompt the conversation include:
- Frequent attacks (four or more per month)
- Attacks that are severe and disabling despite acute treatment
- Overuse of acute medication (leading to medication overuse headache)
- Significant impact on work, relationships, or daily activities
- The presence of certain migraine subtypes, such as hemiplegic migraine or migraine with prolonged aura
Medication-based prevention
Several classes of medication have evidence supporting their use in migraine prevention, as outlined by the Royal Australian College of General Practitioners (RACGP) and NPS MedicineWise:
- Beta-blockers (such as propranolol) — Originally developed for cardiovascular conditions, certain beta-blockers have been shown to reduce migraine frequency. They are often a first-line preventive option.
- Antidepressants (such as amitriptyline) — Low-dose tricyclic antidepressants may help reduce migraine frequency, independent of their effect on mood. They can be particularly useful when migraine coexists with tension-type headache or sleep difficulties.
- Anticonvulsants (such as topiramate and sodium valproate) — These medications, originally used for epilepsy, have demonstrated benefit in migraine prevention. They carry specific side-effect profiles and contraindications, particularly in women of childbearing age, and require careful discussion with a doctor.
- Candesartan — An angiotensin receptor blocker that has shown promise in clinical trials as a preventive treatment and may be a suitable option for some patients.
All preventive medications take time to reach their full effect, typically six to eight weeks at an adequate dose. A GP will usually recommend trialling a preventive medication for at least two to three months before assessing whether it is working. Dose adjustments are common. Finding the right preventive medication often involves a process of careful, guided trial with medical oversight.
Lifestyle and behavioural approaches
Alongside medication, several lifestyle strategies may help reduce migraine frequency:
- Regular sleep — Maintaining a consistent sleep schedule, even on weekends, can help reduce attacks.
- Hydration and regular meals — Skipping meals and dehydration are common and avoidable triggers.
- Stress management — Techniques such as mindfulness, progressive muscle relaxation, and cognitive behavioural therapy (CBT) have been studied as adjuncts to medical treatment for migraine. Headache Australia highlights the role of psychological approaches in comprehensive migraine management.
- Regular physical activity — Moderate, consistent exercise has been associated with reduced migraine frequency in some studies. High-intensity or irregular exercise, however, can be a trigger for some individuals, so it is worth building up gradually and discussing with a GP.
Newer therapies
In recent years, newer treatments such as CGRP (calcitonin gene-related peptide) monoclonal antibodies have become available in Australia for patients with chronic migraine who have not responded to other preventive therapies. These are specialist-prescribed medications typically accessed through a neurologist, and eligibility criteria apply. A GP can provide a referral if this pathway is appropriate.
Not every headache requires a doctor's visit, but there are clear situations where a medical consultation is important. The following are signs that it is time to speak with a GP about migraine:
- Headaches are becoming more frequent or more severe — A change in the pattern of headaches, particularly an increase in frequency, is worth investigating.
- Over-the-counter medication is no longer effective — If simple analgesics are not providing adequate relief, a GP can explore prescription options that may be more suitable.
- Headaches are affecting daily life — Missing work, cancelling plans, or spending days in bed due to headache pain is a signal that current management is not adequate.
- Medication is being used more than 10 to 15 days per month — This is a threshold for medication overuse headache and warrants a clinical review.
- New or unusual symptoms — Any new neurological symptoms, such as sudden onset of severe headache, weakness on one side of the body, confusion, visual loss, or difficulty speaking, should be assessed urgently. These may indicate a condition other than migraine.
- First migraine with aura — If aura symptoms have never occurred before, it is important to have them assessed by a doctor to rule out other neurological causes.
- Migraine and hormonal contraception — Migraine with aura has specific implications for the safety of certain types of hormonal contraception. A GP can advise on the most appropriate options.
It is also worth seeing a doctor simply to get a diagnosis. Many people with migraine have never had the condition formally identified. A diagnosis opens the door to targeted treatments that would not otherwise be considered.
Need migraine treatment?
Migraine is a condition that is well-suited to management through online GP consultations. The diagnosis is primarily clinical, meaning it is based on a detailed history of symptoms rather than physical examination or imaging in most cases. A GP can assess the pattern of headaches, identify triggers, discuss treatment options, prescribe medication, and build a long-term management plan, all through a video consultation.
For patients in regional and remote Australia, where access to a GP may involve long travel times and extended waiting periods, online consultations remove a significant barrier. For working professionals and parents who cannot easily take hours out of their day for a clinic visit, the ability to see a GP from home or from work during a break makes it more likely that treatment will actually happen rather than being deferred indefinitely.
Online consultations are also well-suited to the ongoing nature of migraine management. Migraine is not typically a one-appointment condition. Effective treatment often involves follow-up consultations to assess whether a medication is working, adjust doses, try a different approach, or revisit the management plan as circumstances change. Continuity of care, seeing the same GP across multiple visits, makes this process more efficient and more personalised. The clinician builds an understanding of the patient's specific migraine pattern, what has been tried, what has worked, and what has not.
If a GP determines during a consultation that a referral to a neurologist or headache specialist is warranted, they can arrange that referral and provide the supporting documentation. If a prescription is clinically appropriate, it can be issued electronically during the consultation and sent directly to the patient's preferred pharmacy.
Abby Health is Australia's largest online-first clinic, built around the principle that long-term, continuous GP care should be accessible to every Australian, not just those who live near a well-staffed clinic with short wait times.
For patients managing migraine, Abby Health offers consultations seven days a week, 365 days a year, with a care network of over 300 clinicians. Whether it is an initial assessment, a medication review, or a follow-up appointment to see how a preventive treatment is working, patients can book at a time that fits their schedule.
Continuity matters deeply for a condition like migraine, where the treatment plan is refined over time. At Abby Health, 71 per cent of patients rebook with the same clinician. That means the GP who first assessed the migraine pattern is often the same GP managing treatment months later, already familiar with the patient's triggers, medication history, and response to previous therapies.
Before each consultation, Abby AI, our clinical decision-support tool, surfaces the patient's relevant history, previous prescriptions, and clinical notes for the clinician. This means the GP comes to the appointment informed rather than starting from scratch. Abby AI does not diagnose or prescribe. It supports the clinician so that consultation time is spent on the patient, not on paperwork.
If a prescription is appropriate, it can be issued during the consultation and sent electronically to the patient's pharmacy. If a referral to a specialist is needed, the GP can facilitate that as part of the appointment.
Consultations can be bulk billed for eligible patients with a valid Medicare card. For Australians who have been putting off a conversation about their migraines because getting an appointment felt too difficult, too expensive, or too far away, that barrier no longer needs to exist.
Editorial Standards
Notice something that doesn’t look right? Let us know at support@abbyhealth.app
- Headache Australia. Migraine. headacheaustralia.org.au
- Healthdirect Australia. Migraine. healthdirect.gov.au
- Brain Foundation Australia. Migraine. brainfoundation.org.au
- NPS MedicineWise. Managing migraines. nps.org.au
- Royal Australian College of General Practitioners (RACGP). Clinical guidelines — Headache and migraine. racgp.org.au
- GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019. The Lancet. 2020;396(10258):1204-1222.
- International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211.
- National Health and Medical Research Council (NHMRC). Clinical practice guidelines for the diagnosis and management of headache. nhmrc.gov.au
- Deloitte Access Economics for Headache Australia. Migraine in Australia Whitepaper. headacheaustralia.org.au
- Pharmaceutical Benefits Scheme (PBS). Medicines for migraine. pbs.gov.au




%20Medium.jpeg)
.avif)





